Cees Korstanje
About
In The Last Decade
Cees Korstanje
31 papers receiving 571 citations
Peers
Comparison fields: 5 of 71
- Urology 480
- Rheumatology 203
- Epidemiology 159
- Endocrinology, Diabetes and Metabolism 118
- Surgery 65
Countries citing papers authored by Cees Korstanje
This map shows the geographic impact of Cees Korstanje's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cees Korstanje with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cees Korstanje more than expected).
Fields of papers citing papers by Cees Korstanje
This network shows the impact of papers produced by Cees Korstanje. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cees Korstanje. The network helps show where Cees Korstanje may publish in the future.
Co-authorship network of co-authors of Cees Korstanje
This figure shows the co-authorship network connecting the top 25 collaborators of Cees Korstanje. A scholar is included among the top collaborators of Cees Korstanje based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cees Korstanje. Cees Korstanje is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 13 | |
| 3 | 43 | |
| 4 | 14 | |
| 5 | 7 | |
| 6 | 14 | |
| 7 | 18 | |
| 8 | 18 | |
| 9 | 35 | |
| 10 | Modulation of PGE2-augmented non-voiding activity by ß3-adrenoceptor agonist mirabegron in conscious rats | 1 |
| 11 | Additive effects for increased bladder storage function with the antimuscarinic drug solifenacin and the selective ß3-adrenergic agonist mirabegron in two rat models for in vivo bladder function. | 2 |
| 12 | 63 | |
| 13 | 38 | |
| 14 | 4 | |
| 15 | Differences in the actions of the M3-antagonist tolterodine and the beta 3 adrenoceptor agonist mirabegron on non-voiding activity in rats with partial outflow obstruction | 2 |
| 16 | 16 | |
| 17 | 2 | |
| 18 | Shifting attention from one cell type to another in dermatological research, but where are the new drugs? | 1 |
| 19 | 9 | |
| 20 | 39 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.